Crossover balloon occlusion technique for access closure during transcatheter aortic valve implantation: a multicenter observational study

Abstract The ProGlide system represents the most common approach to close the main access site during transcatheter aortic valve implantation (TAVI). A crossover balloon occlusion technique (CBOT) has been reported in small case-series to possibly provide a controlled, safe, and successful hemostasi...

Full description

Saved in:
Bibliographic Details
Main Authors: Gianluigi Napoli, Arturo Ausiello, Vincenzo Pestrichella, Gianluigi Novielli, Rocco Tritto, Palma Luisa Nestola, Luigi My, Giuseppe Biondi-Zoccai, Nicola Corcione, Arturo Giordano, Sabino Iliceto, Marco Matteo Ciccone, Martino Pepe
Format: Article
Language:English
Published: Nature Portfolio 2025-08-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-13765-y
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849333326449475584
author Gianluigi Napoli
Arturo Ausiello
Vincenzo Pestrichella
Gianluigi Novielli
Rocco Tritto
Palma Luisa Nestola
Luigi My
Giuseppe Biondi-Zoccai
Nicola Corcione
Arturo Giordano
Sabino Iliceto
Marco Matteo Ciccone
Martino Pepe
author_facet Gianluigi Napoli
Arturo Ausiello
Vincenzo Pestrichella
Gianluigi Novielli
Rocco Tritto
Palma Luisa Nestola
Luigi My
Giuseppe Biondi-Zoccai
Nicola Corcione
Arturo Giordano
Sabino Iliceto
Marco Matteo Ciccone
Martino Pepe
author_sort Gianluigi Napoli
collection DOAJ
description Abstract The ProGlide system represents the most common approach to close the main access site during transcatheter aortic valve implantation (TAVI). A crossover balloon occlusion technique (CBOT) has been reported in small case-series to possibly provide a controlled, safe, and successful hemostasis during TAVI. We sought to investigate the comparative performance of a combined (CBOT + ProGlide) compared with a ProGlide only approach. Primary endpoint was VARC-3 type ≥ 2 bleeding. Secondary outcomes included red blood cells transfusion, vascular complications, acute kidney injury (AKI), length of hospital stay (LOS), and death. Our study retrospectively included 229 consecutive patients admitted to “Villa Verde” Clinic (Taranto, Italy) and “Mater Dei” Hospital (Bari, Italy) and treated with TAVI. The study population was divided based on the access closure strategy in two groups: the combined and the ProGlide suture only group. The CBOT + ProGlide treated group presented lower incidence of primary endpoint, as well as less red blood cells transfusions, AKI stages ≥ 2, and shorter LOS. After propensity-score matching, the CBOT + ProGlide group confirmed lower incidence of primary endpoint (2 (2.4%) vs. 10 (11.9%), p = 0.016), of AKI stage ≥ 2 (0 vs. 5 (6%), p = 0.029), and shorter LOS (6.9 ± 4.0 vs. 8.9 ± 6.1, p = 0.015); moreover, the multivariate logistic regression analysis confirmed the protective role of the combined approach against VARC-3 type ≥ 2 bleeding (CI 0.04–0.99; OR 0.2; p = 0.05). Data from this multicenter comparative study highlight that a routinary percutaneous closure of the main TAVI access with ProGlide coupled with CBOT is possible and safe. Moreover, this combined approach seems promising in terms of reduced bleeding, RBC transfusions, AKI incidence, and shortening of hospitalizations.
format Article
id doaj-art-370d7b8a5f1d4a089d8867f9ba19c0e4
institution Kabale University
issn 2045-2322
language English
publishDate 2025-08-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-370d7b8a5f1d4a089d8867f9ba19c0e42025-08-20T03:45:53ZengNature PortfolioScientific Reports2045-23222025-08-0115111010.1038/s41598-025-13765-yCrossover balloon occlusion technique for access closure during transcatheter aortic valve implantation: a multicenter observational studyGianluigi Napoli0Arturo Ausiello1Vincenzo Pestrichella2Gianluigi Novielli3Rocco Tritto4Palma Luisa Nestola5Luigi My6Giuseppe Biondi-Zoccai7Nicola Corcione8Arturo Giordano9Sabino Iliceto10Marco Matteo Ciccone11Martino Pepe12Division of Cardiology, “Villa Verde” ClinicDivision of Cardiology, “Villa Verde” ClinicDivision of Cardiology, “Mater Dei” HospitalDivision of Cardiology, Department of Interdisciplinary Medicine (D.I.M.), University of Bari Aldo MoroDivision of Cardiology, Department of Interdisciplinary Medicine (D.I.M.), University of Bari Aldo MoroDivision of Cardiology, “Mater Dei” HospitalDivision of Cardiology, “Villa Verde” ClinicDepartment of Medical-Surgical Sciences and Biotechnologies, Sapienza University of RomeCardiovascular Interventions Unit, Pineta Grande HospitalCardiovascular Interventions Unit, Pineta Grande HospitalHeart Center Mater Dei Hospital, LUM UniversityDivision of Cardiology, Department of Interdisciplinary Medicine (D.I.M.), University of Bari Aldo MoroDivision of Cardiology, Department of Interdisciplinary Medicine (D.I.M.), University of Bari Aldo MoroAbstract The ProGlide system represents the most common approach to close the main access site during transcatheter aortic valve implantation (TAVI). A crossover balloon occlusion technique (CBOT) has been reported in small case-series to possibly provide a controlled, safe, and successful hemostasis during TAVI. We sought to investigate the comparative performance of a combined (CBOT + ProGlide) compared with a ProGlide only approach. Primary endpoint was VARC-3 type ≥ 2 bleeding. Secondary outcomes included red blood cells transfusion, vascular complications, acute kidney injury (AKI), length of hospital stay (LOS), and death. Our study retrospectively included 229 consecutive patients admitted to “Villa Verde” Clinic (Taranto, Italy) and “Mater Dei” Hospital (Bari, Italy) and treated with TAVI. The study population was divided based on the access closure strategy in two groups: the combined and the ProGlide suture only group. The CBOT + ProGlide treated group presented lower incidence of primary endpoint, as well as less red blood cells transfusions, AKI stages ≥ 2, and shorter LOS. After propensity-score matching, the CBOT + ProGlide group confirmed lower incidence of primary endpoint (2 (2.4%) vs. 10 (11.9%), p = 0.016), of AKI stage ≥ 2 (0 vs. 5 (6%), p = 0.029), and shorter LOS (6.9 ± 4.0 vs. 8.9 ± 6.1, p = 0.015); moreover, the multivariate logistic regression analysis confirmed the protective role of the combined approach against VARC-3 type ≥ 2 bleeding (CI 0.04–0.99; OR 0.2; p = 0.05). Data from this multicenter comparative study highlight that a routinary percutaneous closure of the main TAVI access with ProGlide coupled with CBOT is possible and safe. Moreover, this combined approach seems promising in terms of reduced bleeding, RBC transfusions, AKI incidence, and shortening of hospitalizations.https://doi.org/10.1038/s41598-025-13765-yTAVIProGlideBalloonEndoclampBleeding
spellingShingle Gianluigi Napoli
Arturo Ausiello
Vincenzo Pestrichella
Gianluigi Novielli
Rocco Tritto
Palma Luisa Nestola
Luigi My
Giuseppe Biondi-Zoccai
Nicola Corcione
Arturo Giordano
Sabino Iliceto
Marco Matteo Ciccone
Martino Pepe
Crossover balloon occlusion technique for access closure during transcatheter aortic valve implantation: a multicenter observational study
Scientific Reports
TAVI
ProGlide
Balloon
Endoclamp
Bleeding
title Crossover balloon occlusion technique for access closure during transcatheter aortic valve implantation: a multicenter observational study
title_full Crossover balloon occlusion technique for access closure during transcatheter aortic valve implantation: a multicenter observational study
title_fullStr Crossover balloon occlusion technique for access closure during transcatheter aortic valve implantation: a multicenter observational study
title_full_unstemmed Crossover balloon occlusion technique for access closure during transcatheter aortic valve implantation: a multicenter observational study
title_short Crossover balloon occlusion technique for access closure during transcatheter aortic valve implantation: a multicenter observational study
title_sort crossover balloon occlusion technique for access closure during transcatheter aortic valve implantation a multicenter observational study
topic TAVI
ProGlide
Balloon
Endoclamp
Bleeding
url https://doi.org/10.1038/s41598-025-13765-y
work_keys_str_mv AT gianluiginapoli crossoverballoonocclusiontechniqueforaccessclosureduringtranscatheteraorticvalveimplantationamulticenterobservationalstudy
AT arturoausiello crossoverballoonocclusiontechniqueforaccessclosureduringtranscatheteraorticvalveimplantationamulticenterobservationalstudy
AT vincenzopestrichella crossoverballoonocclusiontechniqueforaccessclosureduringtranscatheteraorticvalveimplantationamulticenterobservationalstudy
AT gianluiginovielli crossoverballoonocclusiontechniqueforaccessclosureduringtranscatheteraorticvalveimplantationamulticenterobservationalstudy
AT roccotritto crossoverballoonocclusiontechniqueforaccessclosureduringtranscatheteraorticvalveimplantationamulticenterobservationalstudy
AT palmaluisanestola crossoverballoonocclusiontechniqueforaccessclosureduringtranscatheteraorticvalveimplantationamulticenterobservationalstudy
AT luigimy crossoverballoonocclusiontechniqueforaccessclosureduringtranscatheteraorticvalveimplantationamulticenterobservationalstudy
AT giuseppebiondizoccai crossoverballoonocclusiontechniqueforaccessclosureduringtranscatheteraorticvalveimplantationamulticenterobservationalstudy
AT nicolacorcione crossoverballoonocclusiontechniqueforaccessclosureduringtranscatheteraorticvalveimplantationamulticenterobservationalstudy
AT arturogiordano crossoverballoonocclusiontechniqueforaccessclosureduringtranscatheteraorticvalveimplantationamulticenterobservationalstudy
AT sabinoiliceto crossoverballoonocclusiontechniqueforaccessclosureduringtranscatheteraorticvalveimplantationamulticenterobservationalstudy
AT marcomatteociccone crossoverballoonocclusiontechniqueforaccessclosureduringtranscatheteraorticvalveimplantationamulticenterobservationalstudy
AT martinopepe crossoverballoonocclusiontechniqueforaccessclosureduringtranscatheteraorticvalveimplantationamulticenterobservationalstudy